# Jianjia Robot

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/jianjia-robot

- Industry: Medical Devices & Equipment
- Headquarters: Hangzhou, China
- Total disclosed funding: $30M
- Latest round: Series C (May 20, 2021)
- Investors on record: 7

## About

Established in 2018 and based in Hangzhou, China, Jianjia Robot is a medical robot developer. The company raised over RMB 100 million in series B funding.

The company focuses on the research and development of orthopedic surgery robots. The surgery robot provides joint replacement solutions covering preoperative, intraoperative and postoperative. The surgery robot offers the surgical plan and helps doctors perform surgery.

Following the funding in May 2021, the company plans to use the investment to advance the clinical trials of surgical robots and the development and clinical registration of new products.

## Funding rounds

- Series C, May 20, 2021, $16M — SB China Venture Capital, LYFE Capital, Shanghai Fosun Pharmaceutical (Group), GL Ventures
- Series B, Sep 7, 2020, $15M — Baidu Ventures, Shanghai Fosun Pharmaceutical (Group), GL Ventures
- Series A, Apr 24, 2020 — Baidu Ventures
- Angel, Feb 22, 2019 — ZJKF Capital Management, Puhua Capital

## Investors

- ZJKF Capital Management (https://capitalatlas.ai/funds/zjkf-capital-management) — Angel
- Puhua Capital (https://capitalatlas.ai/funds/puhua-capital) — Angel
- Baidu Ventures (https://capitalatlas.ai/funds/baidu-ventures) — Series A, Series B
- Shanghai Fosun Pharmaceutical (Group) — Series B, Series C
- GL Ventures (https://capitalatlas.ai/funds/gl-ventures) — Series B, Series C
- SB China Venture Capital (https://capitalatlas.ai/funds/sb-china-venture-capital) — Series C
- LYFE Capital — Series C